TUBERCULOSIS TRENDS DURING CRISES AND CONFLICTS: IMPLICATIONS FOR EPIDEMIC MANAGEMENT
Tuberculosis (TB) remains a major global health challenge, causing significant morbidity and mortality despite advances in diagnostics, treatment, and prevention. In 2022, an estimated 10.6 million people developed TB worldwide, and approximately 1.3 million died, making it the second leading…
COMBATING TB IN AN ERA OF GLOBAL HEALTH CHALLENGES
Tuberculosis (TB), once considered on a path toward eradication, has experienced a concerning resurgence, posing a major global public health threat. Despite being preventable and curable, socio-economic, immunological, and geopolitical factors have hindered TB control, contributing to its re-emergence. In…
ASSESSING CIRCULATING ENDOTROPHIN AS A NON-INVASIVE MARKER OF CHRONIC LIVER FIBROSIS
Chronic liver disease (CLD) is a significant global public health concern, contributing to substantial morbidity and mortality. The prognosis and management of CLD are closely tied to the degree of liver fibrosis, which traditionally has been assessed via liver biopsy,…